| 发明名称 |
Compounds effecting Glucokinase |
| 摘要 |
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R 1 , R 2 , R 3 , n and m are as described in the specification, in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes.
|
| 申请公布号 |
EP1669068(A1) |
申请公布日期 |
2006.06.14 |
| 申请号 |
EP20060001809 |
申请日期 |
2002.08.15 |
| 申请人 |
ASTRAZENECA AB |
发明人 |
JOHNSTONE, CRAIG;JAMES, ROGER;MCKERRECHER, DARREN;BOYD, SCOTT;CAULKETT, PETER;HARGREAVES, RONEY;JONES, CLIFORD DAVID;BOWKER, SUZANNE;BLOCK, MICHAEL HOWARD |
| 分类号 |
A61K31/425;A61K31/165;A61K31/167;A61K31/192;A61K31/195;A61K31/341;A61K31/415;A61K31/4155;A61K31/42;A61K31/426;A61K31/427;A61K31/428;A61K31/433;A61K31/44;A61K31/4402;A61K31/4436;A61K31/4439;A61K31/444;A61K31/445;A61K31/454;A61K31/455;A61K31/496;A61K31/4965;A61K31/497;A61K31/50;A61K31/501;A61K31/505;A61K31/506;A61K31/5377;A61P3/04;A61P3/06;A61P3/10;A61P43/00;C07D213/75;C07D213/76;C07D213/82;C07D213/85;C07D231/40;C07D233/48;C07D237/20;C07D237/24;C07D239/42;C07D239/47;C07D241/20;C07D241/26;C07D241/28;C07D261/14;C07D277/20;C07D277/46;C07D277/54;C07D277/56;C07D277/58;C07D277/82;C07D285/12;C07D285/135;C07D307/66;C07D307/68;C07D401/04;C07D403/04;C07D405/12;C07D409/12;C07D409/14;C07D413/04;C07D413/12;C07D413/14;C07D417/04;C07D417/12;C07D417/14 |
主分类号 |
A61K31/425 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
